-
Nu.Q® Technology
Our technology detects characteristic epigenetic changes in nucleosomes that occur from the earliest stages of cancer, sepsis and other diseases.
-
- Our Tests
- Human Health
-
Nu.Q® NETs
Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.
-
Nu.Q® Discover
Buy our Nu.Q® Discover H3.1 Research Use Only Assay
- Animal Health
-
Nu.Q® Vet Cancer Test
Nu.Q® Vet Cancer Test is an affordable, accessible blood test that detects cancer in dogs.

Webinar series: NETs as a Therapeutic Target
- Share
- Tweet
- Share on Facebook
- Share
NETs as a therapeutic target
In the final video of our series, we discuss how NETs, particularly H3.1 histones, might serve as a potential therapeutic target for treating sepsis. We focus on key studies that explore how blocking or manipulating NETs could mitigate the excessive immune response seen in sepsis.

Find out more about Nu.Q® NETs and our ongoing studies here.
Related Articles
- Share
- Tweet
- Share on Facebook
- Share
Subscribe for Volition product updates.
Or, click here for Investor Updates and press releases.
"*" indicates required fields